EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Restoring RCAN1 dosage mitigates sleep and EEG abnormalities in a Down syndrome model

Peter Cain, Ryan Milstead, Mina Griffioen, Helen Wong, Curtis Borski, Andrew Cooper-Sansone, Lauren LaPlante, Kora Kastengren, Samantha Cotto, Jessica Hanson, Bernhard Freigassner, Christopher Link und 2 weitere

Neurobiology of Disease · 2026-06 · 223 · 107375

DOI: 10.1016/j.nbd.2026.107375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2026-06. Verfasst von Peter Cain und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA. Hauptthemen laut MEDLINE: Down Syndrome, Intracellular Signaling Peptides and Proteins, Muscle Proteins, Sleep. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIMH NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Approximately 60% of individuals with Down syndrome (DS) have sleep abnormalities independent of breathing obstruction. Previously, we demonstrated increased wakefulness and decreased NREM sleep in the Dp(16)1Yey+ (Dp16) DS model mouse. In this study, we determined if increased RCAN1 levels mediate sleep disruption in Dp16 mice. METHODS: We examined sleep architecture and electroencephalogram (EEG) patterns in young and aged Dp16 mice in which we genetically restored disomic levels of Rcan1 (Dp16 Rcan12N, shortened to Dp16-2N). Approximately equal numbers of male and female mice were used for each age group. We also examined gene expression and anxiety-like behaviors in aged mice. RESULTS: We found that young Dp16 and Dp16-2N mice differ slightly from WT mice in sleep architecture and EEG characteristics. However, with age, more severe sleep deficits manifest in Dp16 mice and are partially rescued by Rcan1 dosage correction. Aged Dp16 mice exhibit significantly less mean EEG total power across different sleep states and activity phases. In contrast, WT and Dp16-2N mice show no age-related differences across states and stages. Aged Dp16 mice diverge from aged WT mice across multiple wake and sleep frequency bands during dark and light phases. In contrast, the EEG characteristics of aged Dp16-2N differ only modestly from those of WT mice. CONCLUSIONS: Combined, our data demonstrate that restoring Rcan1 gene levels mitigates some sleep architecture disruptions and EEG differences observed in aged Dp16 mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeIntracellular Signaling Peptides and ProteinsMuscle ProteinsSleepSleep Wake DisordersBrainAnimalsElectroencephalographyFemaleMaleDisease Models, AnimalMiceMice, TransgenicMice, Inbred C57BLAnxiety

Stichwörter der Autor:innen

AgeAnxietyDown syndromeDp16EEGRCAN1SleepTranscriptomics

Substanzen

Intracellular Signaling Peptides and ProteinsMuscle Proteins

Autor:innen und Institutionen

  • Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA.
  • Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA; Linda Crnic Institute, Anschutz Medical Center, Aurora, CO 80045, USA.
  • Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA; Department of Integrative Physiology, University of Colorado, Boulder, CO 80303, USA.
  • Department of Integrative Physiology, University of Colorado, Boulder, CO 80303, USA.
  • Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA; Linda Crnic Institute, Anschutz Medical Center, Aurora, CO 80045, USA; Department of Integrative Physiology, University of Colorado, Bou…

Förderung

  • NIDA NIH HHS
  • NIMH NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute of Mental Health
  • Alzheimer's Association
  • National Institute of Neurological Disorders and Stroke
  • National Institutes of Health

Zitieren

APA

Cain, P., Milstead, R., Griffioen, M., Wong, H., Borski, C., Cooper-Sansone, A., LaPlante, L., Kastengren, K., Cotto, S., Hanson, J., Freigassner, B., Link, C., Opp, M., & Hoeffer, C. (2026). Restoring RCAN1 dosage mitigates sleep and EEG abnormalities in a Down syndrome model. Neurobiology of Disease, 223, 107375. https://doi.org/10.1016/j.nbd.2026.107375

Vancouver

Cain P, Milstead R, Griffioen M, Wong H, Borski C, Cooper-Sansone A, et al. Restoring RCAN1 dosage mitigates sleep and EEG abnormalities in a Down syndrome model. Neurobiology of Disease. 2026;223:107375. doi:10.1016/j.nbd.2026.107375

BibTeX
@article{Cain2026,
  author = {Cain, Peter and Milstead, Ryan and Griffioen, Mina and Wong, Helen and Borski, Curtis and Cooper-Sansone, Andrew and LaPlante, Lauren and Kastengren, Kora and Cotto, Samantha and Hanson, Jessica and Freigassner, Bernhard and Link, Christopher and Opp, Mark and Hoeffer, Charles},
  title = {Restoring RCAN1 dosage mitigates sleep and EEG abnormalities in a Down syndrome model},
  journal = {Neurobiology of Disease},
  year = {2026},
  volume = {223},
  pages = {107375},
  doi = {10.1016/j.nbd.2026.107375}
}
Kostenlos starten →